Since the time you follow us on Croblanc, you are beginning to be used to hear about the Youtube channel Bloomberg Television, and its viral videos that are always talked about on the web, and even beyond! Sometimes we hesitate to write an article because we don't know if you will like it, but today we know that this video will interest you.
The Youtube channel Bloomberg Television has published today a new video called Lilly’s Zepbound beats Novo’s Wegovy in head-to-head trial #shorts #zepbound #wegovy. You want to discover this video and watch it in streaming, you are lucky we put it aside for you!
Big buzz for the moment for this last video of Bloomberg Television, indeed the number of views that the video counts is currently much higher than normal. That's why we imagine that if it continues in this direction, the video could very quickly find itself in Youtube trend.
Do you have a problem with this video? Or did you see a small error in the content you just watched? However, there is no guarantee that they will respond. But nothing ventured, nothing gained! To get in direct contact with a videographer, try to find his social networks and send him a public or private message. You can also find the email of a Youtuber on his Youtube channel by clicking on "About". This will give you his precious email address.
Feel free to give us feedback on social networks if you enjoyed reading this article about the video Lilly’s Zepbound beats Novo’s Wegovy in head-to-head trial #shorts #zepbound #wegovy. Did you know that? On Youtube, you can find other videos of Bloomberg Television that have been uploaded by other users and that are not yet referenced on Croblanc. If you are curious, go and have a look, you never know!
Looking forward to discovering new contents with you, see you next time on Croblanc!
For your information, you can find below the description of the video Lilly’s Zepbound beats Novo’s Wegovy in head-to-head trial #shorts #zepbound #wegovy published by the Youtube channel Bloomberg Television:
Eli Lilly said its weight-loss drug Zepbound outperformed rival Novo Nordisk's Wegovy in the first head-to-head trial of the two blockbusters. Dr. Daniel Skovronsky, Eli Lilly chief scientific officer, spoke to Bloomberg TV about the results https://trib.al/Y3suGBA